Skip to main content

CORRECTION article

Front. Bioeng. Biotechnol., 30 January 2020
Sec. Nanobiotechnology
Volume 7 - 2019 | https://doi.org/10.3389/fbioe.2019.00468
This article is part of the Research Topic Advanced Theranostic Nanomedicine in Oncology View all 14 articles

Corrigendum: Theranostic Nanomedicine for Malignant Gliomas

\nMichele d&#x;AngeloMichele d'Angelo1Vanessa CastelliVanessa Castelli1Elisabetta BenedettiElisabetta Benedetti1Andrea AntonosanteAndrea Antonosante1Mariano CatanesiMariano Catanesi1Reyes Dominguez-BenotReyes Dominguez-Benot1Giuseppina PitariGiuseppina Pitari1Rodolfo IppolitiRodolfo Ippoliti1Annamaria Cimini, Annamaria Cimini1,2*
  • 1Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy
  • 2Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA, United States

A Corrigendum on
Theranostic Nanomedicine for Malignant Gliomas

by d'Angelo, M., Castelli, V., Benedetti, E., Antonosante, A., Catanesi, M., Dominguez-Benot, R., et al. (2019). Front. Bioeng. Biotechnol. 7:325. doi: 10.3389/fbioe.2019.00325

In the original article, we neglected to include the funder. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 713714 to Reyes Dominguez-Benot.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: theranostic nanoplatform, brain tumors, targeted therapy, drug delivery, diagnosis

Citation: d'Angelo M, Castelli V, Benedetti E, Antonosante A, Catanesi M, Dominguez-Benot R, Pitari G, Ippoliti R and Cimini A (2020) Corrigendum: Theranostic Nanomedicine for Malignant Gliomas. Front. Bioeng. Biotechnol. 7:468. doi: 10.3389/fbioe.2019.00468

Received: 19 December 2019; Accepted: 20 December 2019;
Published: 30 January 2020.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 d'Angelo, Castelli, Benedetti, Antonosante, Catanesi, Dominguez-Benot, Pitari, Ippoliti and Cimini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Annamaria Cimini, YW5uYW1hcmlhLmNpbWluaSYjeDAwMDQwO3VuaXZhcS5pdA==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.